Scrip Pharma: Deal Watch: Best Value for Smaller Firms Lies in the Back End News, Vasilios Kofitsas PostsInvestment Banking TeamFebruary 7, 2017Biopharma Financing, Investment Banking, Transactions
Back Bay in Wall Street Journal Newsletter: Biotech M&A Deals Expected to Increase Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsJanuary 17, 2017M&A, Investment Banking, Life Science IPOs
Back Bay in US News and World Report: Biggest Financial Headlines of 2016 Jonathan Gertler Posts, News, Back Bay in the NewsBack Bay Life Science AdvisorsJanuary 3, 2017Investment Banking, Biotech Financing
Scrip Intelligence: Early-Stage Funding Slips Again (VC Roundup) Back Bay in the News, NewsBack Bay Life Science AdvisorsDecember 9, 2016VC, Investment Banking, Biotech Funding
Back Bay in the Boston Globe: Crispr IPO Doesn't Hit It's Target News, Back Bay in the NewsBack Bay Life Science AdvisorsOctober 24, 2016Gene Editing, IPO, Investment Banking
